Vestal Point Capital »

Achilles Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 1.5M 0.82

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Achilles Therapeutics

Syncona Portfolio
Fcpm Iii Services B.v.
Redmile Group
Vestal Point Capital
Ikarian Capital
Baker Bros. Advisors
Artal Group
Renaissance Technologies
BML Capital Management
Acadian Asset Management
Citadel Advisors
XTX Topco
Two Sigma Advisers
Virtu Financial
Geode Capital Management

View all funds holding Achilles Therapeutics